Trials / Conditions / Pneumococcal Pneumonia

Pneumococcal Pneumonia

11 registered clinical trials studyying Pneumococcal Pneumonia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial NCT06699433	Southern Medical University, China	N/A
Completed	Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults NCT07354425	Universidad de la Sabana	—
Completed	Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket NCT03851978	Virginia Commonwealth University	N/A
Completed	Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents NCT03619252	Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology	Phase 4
Completed	Phase I to Test a New Pneumococcal Vaccine NCT03303976	LimmaTech Biologics AG	Phase 1
Completed	The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal NCT02592486	Kameda Medical Center	Phase 4
Completed	Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults NCT01444352	Sanofi Pasteur, a Sanofi Company	Phase 1
Completed	Study of Two Investigational Pneumococcal Vaccines in Healthy Adults NCT01444339	Sanofi	Phase 1
Unknown	PCV10 Reactogenicity and Immunogenicity Study - Malindi NCT01028326	KEMRI-Wellcome Trust Collaborative Research Program	Phase 4
Completed	Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers NCT01444001	Sanofi	Phase 1
Completed	Targeting of Immune Response After Pneumococcal Vaccination NCT01402245	Helsinki University Central Hospital	Phase 4